Evidence map›Paper›PMID 38417598›Full record

Observational studyHeart rhythm2024

Expedited loading with intravenous sotalol is safe and feasible-primary results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry.

Benjamin A Steinberg, Richard Holubkov, Thomas Deering, Christopher A Groh, Suneet Mittal, Robert Kennedy, Parash Pokharel, Marco Perez, Salvatore Savona, Nishant Verma and 3 more

Open access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Heart rhythm, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Selected Updates in Anti-arrhythmic Drug Therapy and Anticoagulants: 2024.The Journal of innovations in cardiac rhythm management · 2025
    Article
  6. Safety and feasibility of intravenous sotalol loading for the prevention of ventricular arrhythmias.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Benjamin A SteinbergDivision of Cardiovascular Medicine, University of Utah Health, Salt Lake City, Utah. Electronic address: benjamin.steinberg@hsc.utah.edu.
Richard HolubkovData Coordinating Center, Department of Pediatrics, Spencer Eccles Fox School of Medicine, University of Utah, Salt Lake City, Utah.
Thomas DeeringPiedmont Heart Institute, Atlanta, Georgia.
Christopher A GrohDivision of Cardiovascular Medicine, University of Utah Health, Salt Lake City, Utah.
Suneet MittalThe Valley Hospital, Ridgewood, New Jersey.
Robert KennedyMunson Healthcare, Traverse City, Michigan.
Parash PokharelGeisinger Medical Center, Danville, Pennsylvania.
Marco PerezDepartment of Medicine, Stanford University, Stanford, California.
Salvatore SavonaDepartment of Medicine, The Ohio State University, Columbus, Ohio.
Nishant VermaDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Kevin WattDivision of Clinical Pharmacology, Department of Pediatrics, Spencer Eccles Fox School of Medicine, University of Utah, Salt Lake City, Utah.
Jonathan P PicciniDepartment of Medicine, Duke University Medical Center, Durham, North Carolina.
T Jared BunchDivision of Cardiovascular Medicine, University of Utah Health, Salt Lake City, Utah.
University of Utah · USDuke Medical Center · USGeisinger Medical Center · USLebanon Valley College · USMunson Medical Center · USNorthwestern University · USPiedmont Atlanta Hospital · USStanford University · USThe Ohio State University · US

Funding

CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
Neurocognition and Greater Maintenance of Sinus Rhythm in AF (NOGGIN AF)R01AG074185 · NIA · DUKE UNIVERSITY · PI MATHEW, JOSEPH P, PICCINI, JONATHAN PAUL · 2021 to 2025
$3.7M
Optimizing Outcomes for Patients with Heart Failure and Atrial FibrillationK23HL143156 · NHLBI · UNIVERSITY OF UTAH · PI STEINBERG, BENJAMIN ADAM · 2018 to 2022
$951k
NCATS NIH HHS UM1 TR004409NHLBI NIH HHS K23 HL143156NIA NIH HHS R01 AG074185
6 · The paper itself

Abstract

backgroundLoading of oral sotalol for atrial fibrillation requires 3 days, frequently in the hospital, to achieve steady state. The Food and Drug Administration approved loading with intravenous (IV) sotalol through model-informed development, without patient data.

objectiveWe present results of the first multicenter evaluation of this recent labeling for IV sotalol.

methodsThe Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry was a multicenter observational registry of patients undergoing elective IV sotalol load for atrial arrhythmias. Outcomes, measured from hospital admission until first outpatient follow-up, included adverse arrhythmia events, efficacy, and length of stay.

resultsOf 167 consecutively enrolled patients, 23% were female; the median age was 68 (interquartile range, 61-74) years, and the median CHA

conclusionIV sotalol loading is safe and feasible for atrial arrhythmias, with low rates of adverse events, and yields shorter hospitalizations. More data are needed on the minimal duration required for monitoring in the hospital.

Indexed as

Anti-Arrhythmia AgentsAtrial FibrillationRegistriesSotalolAdministration, IntravenousAgedDose-Response Relationship, DrugFemaleFollow-Up StudiesHumansInfusions, IntravenousMaleMiddle AgedProspective StudiesTreatment OutcomeAnti-Arrhythmia AgentsSotalolAntiarrhythmic drugsAtrial fibrillationIntravenous sotalolOutcomesRegistry

Identifiers

PMID38417598
PMCPMC11222028
OpenAlexW4392246221

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.